Related Experiment Videos

Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients

Kaleb M Pauley1, Minoru Satoh, Annie L Chan

  • 1Department of Oral Biology, University of Florida, Gainesville, Florida 32610, USA.

Arthritis Research & Therapy
|September 2, 2008
PubMed
Abstract

Insights

MicroRNA expression is altered in rheumatoid arthritis (RA) patients, with increased miR-146a potentially contributing to disease by prolonging tumor necrosis factor-alpha production. This finding may aid in RA diagnosis and treatment.

Area of Science:

  • Molecular biology
  • Immunology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • Aberrant miRNA expression is implicated in cancer, with emerging roles in autoimmune diseases.
  • This study investigates miRNA expression in rheumatoid arthritis (RA).

Purpose of the Study:

  • To examine the expression of specific microRNAs in peripheral blood mononuclear cells (PBMCs) from RA patients.
  • To investigate the functional consequence of altered miRNA expression on RA pathogenesis.
  • To explore the potential of miRNAs as diagnostic or prognostic markers for RA.

Main Methods:

  • Total RNA isolation from PBMCs of RA patients and controls.
  • Quantitative real-time PCR analysis of miR-146a, miR-155, miR-132, miR-16, and let-7a expression.
  • Analysis of miRNA targets (TRAF6, IRAK-1) and their impact on tumor necrosis factor-alpha production.

Main Results:

  • RA PBMCs showed significantly increased expression of miR-146a, miR-155, miR-132, and miR-16 (1.8- to 2.6-fold).
  • let-7a expression remained unchanged in RA patients compared to controls.
  • Increased miR-146a correlated with reduced tumor necrosis factor-alpha production, suggesting impaired function.

Conclusions:

  • miRNA expression patterns in RA PBMCs mirror those in synovial tissue.
  • Altered miRNA expression, particularly miR-146a, may contribute to RA pathogenesis via dysregulated tumor necrosis factor-alpha production.
  • These miRNAs could serve as potential biomarkers for RA diagnosis, progression, or treatment efficacy, pending further validation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...